Skip to content

Effect of continuous management of diabetes based on multi-disciplinary team: a 36-month, multi-center, open-label, prospective, randomized controlled trial

Effect of continuous management of diabetes based on multi-disciplinary team: a 36-month, multi-center, open-label, prospective, randomized controlled trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023603
Enrollment
Unknown
Registered
2019-06-03
Start date
2019-05-23
Completion date
Unknown
Last updated
2019-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Interventions

Intervention:Continuous management of diabetes based on multi-disciplinary team
Control:Routine outpatient magagement

Sponsors

Peking University First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-80 (inclusive) years with type 2 diabetes who can visit the endocrine Department of six research centers(= 3 times a year) within the next three years; 2. Voluntary signature of informed consent; 3. Patients willing to cooperate with outpatient diabetes management.

Exclusion criteria

Exclusion criteria: 1. Organ failure or other serious diseases, including myocardial infarction occurring within 12 months before entering the group, severe mental disorders, severe infections, diffuse intravascular coagulation, etc.; 2. Active or inactive malignant tumors with a life expectancy of less than 1 year; 3. Patients with communication difficulties who can not fully understand or cooperate; 4. Patients who have accepted continuous management based on multi-disciplinary team by phones/Apps; 5. Pregnant women, lactating women and women who have had conception plans in the past year.

Design outcomes

Primary

MeasureTime frame
HbA1c;Blood pressure;LDL-C;

Secondary

MeasureTime frame
BMI;Chinese version Diabetes Management Self-Efficacy Scale; C-DMSES;Summary of Diabetes Self Care Action; SDSCA;Morisky Medication Adherence Scale;adjusted diabetes quality of life measure; A-DQOL;DASS-C21;Mental Status Questionaire;MSQ;Incidence of new onset diabetes complications;Progress on diabetes complications;Major adverse cardiovascular events;Incidence of hospitalization;Incidence of malignant neoplasms;Incidence of all deaths;

Countries

China

Contacts

Public ContactJunqing Zhang

Peking University First Hospital

junqing.zhang@pkufh.cn+86 13611167278

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026